REGISTERED NUMBER: 13718906 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 NOVEMBER 2025

FOR

JM UROLOGY LIMITED

Page

Balance Sheet

1

FIXED ASSETS

22,235

4,733

CURRENT ASSETS

401,954

360,219

CREDITORS

Amounts falling due within one year

(73,822

)

(68,894

)

NET CURRENT ASSETS

328,132

291,325

TOTAL ASSETS LESS CURRENT LIABILITIES

350,367

296,058

CAPITAL AND RESERVES

350,367

296,058

NOTES TO THE FINANCIAL STATEMENTS

1.	STATUTORY INFORMATION

JM Urology Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

13718906

Registered office:

Rex Buildings

Alderley Road

Wilmslow

Cheshire

SK9 1HY

2.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 3 (2024 - 3 ) .

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 1 May 2026 and were signed on its behalf by:

Mr J McFarlane - Director